Selective Benefit of Adjuvant Chemotherapy in Stage II dMMR Colon Cancer with High-Risk Features or Poorly Differentiated Histology: A Retrospective Study

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC12939670 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature